Embecta Corp. Stock price

Equities

EMBC

US29082K1051

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
13.27 USD +2.87% Intraday chart for Embecta Corp. +2.95% -29.90%
Sales 2024 * 1.11B Sales 2025 * 1.11B Capitalization 764M
Net income 2024 * 51M Net income 2025 * 99M EV / Sales 2024 * 1.71 x
Net Debt 2024 * 1.13B Net Debt 2025 * 1.01B EV / Sales 2025 * 1.59 x
P/E ratio 2024 *
15.1 x
P/E ratio 2025 *
7.88 x
Employees 2,200
Yield 2024 *
4.21%
Yield 2025 *
4.19%
Free-Float 99.68%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.87%
1 week+2.95%
Current month-7.07%
1 month-7.98%
3 months-29.68%
6 months-12.81%
Current year-29.90%
More quotes
1 week
12.32
Extreme 12.32
13.60
1 month
12.32
Extreme 12.32
14.53
Current year
12.32
Extreme 12.32
19.79
1 year
12.32
Extreme 12.32
32.00
3 years
0.00
Extreme 0
49.00
5 years
0.00
Extreme 0
49.00
10 years
0.00
Extreme 0
49.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 22-03-21
Director of Finance/CFO 51 22-03-21
Chief Tech/Sci/R&D Officer 60 21-09-30
Members of the board TitleAgeSince
Director/Board Member 68 22-03-31
Director/Board Member 60 22-03-31
Director/Board Member 58 22-03-19
More insiders
Date Price Change Volume
24-03-28 13.27 +2.87% 316,423
24-03-27 12.9 +4.45% 295,700
24-03-26 12.35 -1.44% 301,153
24-03-25 12.53 +0.97% 414,521
24-03-22 12.41 -4.46% 249,347

Delayed Quote Nasdaq, March 28, 2024 at 04:00 pm EDT

More quotes
Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes. The Company has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The Company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
13.27 USD
Average target price
16.5 USD
Spread / Average Target
+24.34%
Consensus
  1. Stock
  2. Equities
  3. Stock Embecta Corp. - Nasdaq